Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1986 2
1987 1
1989 1
1990 1
1991 3
1992 2
1993 4
1994 4
1996 2
1997 1
1998 6
1999 11
2000 5
2001 7
2002 6
2003 5
2004 6
2005 5
2006 3
2007 1
2009 1
2010 2
2011 1
2012 2
2013 4
2014 8
2016 3
2017 3
2018 4
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Phase I therapy trials in children with cancer.
Shah S, Weitman S, Langevin AM, Bernstein M, Furman W, Pratt C. Shah S, et al. Among authors: weitman s. J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):431-8. doi: 10.1097/00043426-199809000-00005. J Pediatr Hematol Oncol. 1998. PMID: 9787315 Review.
New drug development for pediatric oncology.
Weitman S, Carlson L, Pratt CB. Weitman S, et al. Invest New Drugs. 1996;14(1):1-10. doi: 10.1007/BF00173677. Invest New Drugs. 1996. PMID: 8880388 Review. No abstract available.
Combined venetoclax and alvocidib in acute myeloid leukemia.
Bogenberger J, Whatcott C, Hansen N, Delman D, Shi CX, Kim W, Haws H, Soh K, Lee YS, Peterson P, Siddiqui-Jain A, Weitman S, Stewart K, Bearss D, Mesa R, Warner S, Tibes R. Bogenberger J, et al. Among authors: weitman s. Oncotarget. 2017 Nov 3;8(63):107206-107222. doi: 10.18632/oncotarget.22284. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29291023 Free PMC article.
Antitumor activity of a kinesin inhibitor.
Sakowicz R, Finer JT, Beraud C, Crompton A, Lewis E, Fritsch A, Lee Y, Mak J, Moody R, Turincio R, Chabala JC, Gonzales P, Roth S, Weitman S, Wood KW. Sakowicz R, et al. Among authors: weitman s. Cancer Res. 2004 May 1;64(9):3276-80. doi: 10.1158/0008-5472.can-03-3839. Cancer Res. 2004. PMID: 15126370
101 results